Investors in Healthtec

Passion Capital is a partnership of entrepreneurs and operators who are applying our experiences to helping founders and early-stage teams build great digital media/technology companies. We are committed to fostering an ecosystem of technology, collaboration and executional excellence in Europe, and we believe that the critical differentiator and key asset of a successful business is the passion and ability of its founders. We take pride in the calibre and success of all of our founders and teams including but nowhere near limited to GoCardless, Tray.io, Mendeley, Digital Shadows, urban, Adzuna, Smarkets, Ravelin, Nested, Tide, Spill, Marshmallow, Butternut Box,, PolyAI, Lendable and Monzo Bank

We are a new generation of venture capital funders backing exceptional female founders and gender-balanced teams. SISTAFUND is a pan-European VC fund backing female founders and gender-balanced teams, building companies that challenge the status quo. With a target of €100 million, SISTAFUND will be deployed from pre-seed to Series A, mainly in France and Europe, with some investments in the U.S. SISTAFUND’s ambition is twofold: Drive the performance of backed companies, since start-ups founded or co-founded by women are 2.5 times more profitable investments than others (BCG study, 2018). Accelerate a new generation of diversified leaders, by supporting start-ups with at least one female co-founder

WestTech Ventures, a Berlin-based investment firm, partners with emerging VC funds in Europe and pre-seed & seed startups in Germany dedicated to making a positive global impact through technology.

Masawa invests in European startups catalyzing mental health and wellness. Our Nurture Capital approach minimizes risk, enhances founder wellbeing, repurposes capital, and optimizes financial and social returns.

The first NHS-founded and backed venture fund for digital health and MedTech. Accelerating the future of healthcare in the UK and beyond.

Early-stage Fintech, DeepTech, and x-Tech investment across the UK, Europe, MNA, and APAC regions. We’re a UK based fund with a genuine curiosity for new challenges that have potential to expand to other continents, having backed founders from diverse backgrounds. Good ideas know no borders. And neither do our investments.

Gilde Healthcare is a specialized healthcare investor managing over €2.6 billion across two fund strategies: Venture&Growth and Private Equity. Gilde Healthcare is headquartered in Utrecht (the Netherlands) with local offices in Frankfurt (Germany) and Boston (USA). Gilde Healthcare differentiates itself through its deep sector knowledge in healthcare, which has been acquired during the past decades. The investment team consisting of industry experts, ex-consultants and investors provides hands-on support to its managers in designing the growth strategy and by contributing domain expertise. Gilde Healthcare believes optimal value creation in healthcare is associated with better care at lower cost.

The fund is primarily supported by institutional investors, including public bank Bpifrance and insurance companies MACSF, Sogécap, and Crédit Agricole Assurances. Varsity has collaborated with asset management firm Elevation Capital Partners to establish a feeder fund that will contribute to the VC's second closing.

The healthtech arm of IPQ Capital, the Family Office of Fryland Møller Pathiraja family. We invest in ambitious European healthtech companies at Seed and Series A. Our deep medical expertise, powerful network and agile approach enable founders to build important, world-class healthcare businesses.

Easo Ventures is a Basque Private Venture Capital Company created with the aim of supporting people and companies that have a clear growth project, providing investment, advice and experience. They focus on partnering with innovative projects that demonstrate clear growth potential and are in their initial phases of development, led by capable entrepreneurs. Their offerings include an Acceleration Program hosted at BerriUp and an investment amounting to €50,000, with further details accessible at BerriUp.com. Moving into Phase 1, they prioritize companies equipped with a well-defined growth strategy and a proven business model, supported by a capable team capable of managing and expanding the project. In this phase, investments range from €100,000 to €1 million, complemented by comprehensive support and advisory services provided by their experienced team.

Myelin VC is Investing in companies that accelerate collective intelligence. They collaborate with visionary outliers to pioneer the unimaginable, investing in founders whose ideas shape a future they envision living in. Their investment strategy spans across industries, from seed funding to Series A, supporting innovative ventures poised to disrupt and redefine their respective fields.

Columbus is a Spanish investment management company that focuses on generating high returns through the Columbus Innvierte Life Science fund. This fund targets seed-stage investments in established private companies within the healthcare and life sciences sectors. The company boasts a robust investment team with international experience and a proven track record in identifying innovative excellence originating from Spanish academic institutions. COLUMBUS VENTURE PARTNERS, SGEIC, SA leverages its expertise in company building and financing to accelerate commercialization for its portfolio companies. Additionally, it facilitates rapid access to the vibrant UK and Boston/Cambridge biotech/pharma venture capital R&D ecosystem.